Xiaobao Gong

895 total citations
25 papers, 742 citations indexed

About

Xiaobao Gong is a scholar working on Molecular Biology, Pharmacology and Cancer Research. According to data from OpenAlex, Xiaobao Gong has authored 25 papers receiving a total of 742 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 7 papers in Pharmacology and 4 papers in Cancer Research. Recurrent topics in Xiaobao Gong's work include Pharmacological Effects of Natural Compounds (5 papers), Genomics, phytochemicals, and oxidative stress (3 papers) and Drug-Induced Hepatotoxicity and Protection (3 papers). Xiaobao Gong is often cited by papers focused on Pharmacological Effects of Natural Compounds (5 papers), Genomics, phytochemicals, and oxidative stress (3 papers) and Drug-Induced Hepatotoxicity and Protection (3 papers). Xiaobao Gong collaborates with scholars based in China and United States. Xiaobao Gong's co-authors include Baoshun Zhang, Kai Yang, You Yang, Peng Zhang, Qingyan Zhang, Hong Tang, Xiaoli Ye, Liang Jin, Jiankang Wang and Yutong He and has published in prestigious journals such as ACS Applied Materials & Interfaces, Carbohydrate Polymers and Journal of Ethnopharmacology.

In The Last Decade

Xiaobao Gong

24 papers receiving 733 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiaobao Gong China 17 349 137 80 77 76 25 742
Soraya Sajadimajd Iran 14 438 1.3× 66 0.5× 75 0.9× 76 1.0× 63 0.8× 46 957
Sana Irfan Khan India 15 321 0.9× 107 0.8× 65 0.8× 56 0.7× 73 1.0× 31 946
Jingwei Tian China 22 497 1.4× 102 0.7× 96 1.2× 61 0.8× 90 1.2× 52 1.1k
Jae Lee South Korea 18 367 1.1× 70 0.5× 72 0.9× 50 0.6× 54 0.7× 33 942
Ting‐Lin Yen Taiwan 17 389 1.1× 129 0.9× 67 0.8× 69 0.9× 120 1.6× 49 939
Angela Ladurner Austria 20 392 1.1× 134 1.0× 59 0.7× 67 0.9× 109 1.4× 30 869
Kang Pa Lee South Korea 19 368 1.1× 85 0.6× 47 0.6× 82 1.1× 59 0.8× 64 879
Liwei Gu China 18 348 1.0× 104 0.8× 58 0.7× 67 0.9× 65 0.9× 46 747
Peng Chu China 21 581 1.7× 76 0.6× 62 0.8× 122 1.6× 49 0.6× 44 1.1k

Countries citing papers authored by Xiaobao Gong

Since Specialization
Citations

This map shows the geographic impact of Xiaobao Gong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaobao Gong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaobao Gong more than expected).

Fields of papers citing papers by Xiaobao Gong

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaobao Gong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaobao Gong. The network helps show where Xiaobao Gong may publish in the future.

Co-authorship network of co-authors of Xiaobao Gong

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaobao Gong. A scholar is included among the top collaborators of Xiaobao Gong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaobao Gong. Xiaobao Gong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Gong, Xiaobao, et al.. (2025). Staphylococcal Drug Resistance: Mechanisms, Therapies, and Nanoparticle Interventions. Infection and Drug Resistance. Volume 18. 1007–1033. 5 indexed citations
3.
Yuan, Jing, Xiaobao Gong, Yue Zhu, et al.. (2025). A high-affinity antibody-drug conjugates Actuximab-MMAE for potent and selective targeting of CEACAM5-Positive tumors. Cancer Letters. 620. 217685–217685. 2 indexed citations
4.
Wang, Yaping, Linglong Li, Lei Shi, et al.. (2025). Role and Therapeutic Potential of miR-301b-3p in Regulating the PI3K-AKT Pathway via PIK3CB in Eosinophilic Chronic Rhinosinusitis. Journal of Inflammation Research. Volume 18. 10235–10251.
5.
Gong, Xiaobao, Zhipeng Zhang, Xiang Shi, et al.. (2024). Structural elucidation and anti-psoriasis activity of a novel polysaccharide from Saussurea Costus. Carbohydrate Polymers. 333. 121963–121963. 19 indexed citations
6.
7.
Gong, Xiaobao, Shun Yang, Jinke Li, et al.. (2022). Synthesis and anti-inflammatory activity of paeonol derivatives with etherized aryl urea by regulating TLR4/MyD88 signaling pathway in RAW264.7 cell. Bioorganic Chemistry. 127. 105939–105939. 5 indexed citations
8.
Xiao, Yaping, Yan Liu, Chunming Li, et al.. (2021). An integrated network pharmacology and transcriptomic method to explore the mechanism of the total Rhizoma Coptidis alkaloids in improving diabetic nephropathy. Journal of Ethnopharmacology. 270. 113806–113806. 40 indexed citations
9.
Xiao, Yaping, Chunming Li, Xiaobao Gong, et al.. (2021). Epiberberine ameliorated diabetic nephropathy by inactivating the angiotensinogen (Agt) to repress TGFβ/Smad2 pathway. Phytomedicine. 83. 153488–153488. 19 indexed citations
10.
Gong, Xiaobao, Hong Tang, & Kai Yang. (2021). PER1 suppresses glycolysis and cell proliferation in oral squamous cell carcinoma via the PER1/RACK1/PI3K signaling complex. Cell Death and Disease. 12(3). 276–276. 54 indexed citations
11.
Liu, Huan, Xiaobao Gong, & Kai Yang. (2020). Overexpression of the clock gene Per2 suppresses oral squamous cell carcinoma progression by activating autophagy via the PI3K/AKT/mTOR pathway. Journal of Cancer. 11(12). 3655–3666. 30 indexed citations
12.
Gong, Xiaobao, et al.. (2020). Cordycepin attenuates high-fat diet-induced non-alcoholic fatty liver disease via down-regulation of lipid metabolism and inflammatory responses. International Immunopharmacology. 91. 107173–107173. 38 indexed citations
13.
Yao, Hanchun, Xiaofang Guo, Huijuan Zhou, et al.. (2020). Mild Acid-Responsive “Nanoenzyme Capsule” Remodeling of the Tumor Microenvironment to Increase Tumor Penetration. ACS Applied Materials & Interfaces. 12(18). 20214–20227. 54 indexed citations
14.
Long, Wen, Xiaobao Gong, Yixin Yang, & Kai Yang. (2020). Downregulation of PER2 Promotes Tumor Progression by Enhancing Glycolysis via the Phosphatidylinositol 3-Kinase/Protein Kinase B Pathway in Oral Squamous Cell Carcinoma. Journal of Oral and Maxillofacial Surgery. 78(10). 1780.e1–1780.e14. 13 indexed citations
15.
Wang, Jiankang, et al.. (2019). Perilla oil regulates intestinal microbiota and alleviates insulin resistance through the PI3K/AKT signaling pathway in type-2 diabetic KKAy mice. Food and Chemical Toxicology. 135. 110965–110965. 70 indexed citations
16.
Jia, Yanan, Yalin Peng, Baoshun Zhang, et al.. (2018). Oxyresveratrol prevents lipopolysaccharide/d-galactosamine-induced acute liver injury in mice. International Immunopharmacology. 56. 105–112. 43 indexed citations
17.
Gong, Xiaobao, et al.. (2017). Hepatoprotective effect of quercetin against LPS/ d -GalN induced acute liver injury in mice by inhibiting the IKK/NF-κB and MAPK signal pathways. International Immunopharmacology. 52. 281–289. 86 indexed citations
18.
Gong, Xiaobao, et al.. (2017). Antioxidation, anti-inflammation and anti-apoptosis by paeonol in LPS/ d -GalN-induced acute liver failure in mice. International Immunopharmacology. 46. 124–132. 63 indexed citations
19.
Zhang, Baoshun, You Yang, Xiaobao Gong, et al.. (2016). Synthesis and anti-inflammatory activity of paeonol analogues in the murine model of complete Freund’s adjuvant induced arthritis. Bioorganic & Medicinal Chemistry Letters. 26(21). 5218–5221. 21 indexed citations
20.
Wang, Yue, Yulong Han, Hongmei Xiang, et al.. (2016). The antihypercholesterolemic effect of columbamine from Rhizoma Coptidis in HFHC-diet induced hamsters through HNF-4α/FTF-mediated CYP7A1 activation. Fitoterapia. 115. 111–121. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Soraya Sajadimajd Breakdown of academic impact, for papers by Sana Irfan Khan Breakdown of academic impact, for papers by Jingwei Tian Breakdown of academic impact, for papers by Jae Lee Breakdown of academic impact, for papers by Ting‐Lin Yen Breakdown of academic impact, for papers by Angela Ladurner Breakdown of academic impact, for papers by Kang Pa Lee Breakdown of academic impact, for papers by Liwei Gu Breakdown of academic impact, for papers by Peng Chu
Rankless by CCL
2026